Inhibiting Electrical Activity in Rare, Seizure Disorders

Alex Aimetti, chief scientific officer of Marinus Pharmaceuticals, discusses the company’s drug Ztalmy to treat seizures in people with CDKL5 deficiency disorder, how it works, and the efforts to expand its use to other seizure disorders.